Chemerin is an adipocytokine having cardiovascular effects. Chemokine-like receptor 1
(CMKLR1) and chemokine (CC motif) receptor-like 2 (CCRL2) are chemerin receptors …

Background While chemerin has been shown to increase proliferation and migration of
systemic vascular smooth muscle cells (SMCs) contributing therefore to the development of …

Pulmonary arterial hypertension (PAH) is an incurable disease with high mortality. Chemerin
has been found to be associated with pulmonary hypertension (PH). However, the specific …

Objective—Obesity and hypertension are comorbid in epidemic proportion, yet their
biological connection is largely a mystery. The peptide chemerin is a candidate for …

Background Circulating levels of chemerin are significantly higher in hypertensive patients
and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 …

Since chemerin is an adipocytokine whose concentration in blood increases in the subjects
with various cardiac diseases, chemerin may be involved in pathogenesis of cardiac …

Chemerin acting via its distinct G protein-coupled receptor CMKLR1 (ChemR23), is a novel
adipokine, circulating levels of which are raised in inflammatory states. Chemerin shows …

Vascular remodeling is a characteristic pathogenesis of hypertension and a main cause of
abnormal construction and function of organs because of hypertension. Chemerin is a new …

Blood chemerin concentration shows positive correlation not only with body mass index and
serum triglyceride level but also with systolic blood pressure. While it seems likely that …

Aims Chemerin has been recently identified as a vasoactive adipokine implicated in blood
pressure regulation. In this context, we evaluated whether chemerin could influence …